PATIENT DEMOGRAPHICS

Most participants had been diagnosed with colon cancer and had Stage III disease (Figure 5). The median age was 55, 67 percent of participants were female, 86 percent were Caucasian and 79 percent had some college education. Approximately half had received adjuvant therapy with oxaliplatin and a fluoropyrimidine (mainly variations of FOLFOX), and the other half had mostly received a fluoropyrimidine alone. At the time of the survey, 87 percent of the patients were free of cancer recurrence.

The educational content presented on the audio program was evaluated for understandability and relevance. Despite the relatively sophisticated concepts presented, most patients stated that they understood the information completely or almost completely (Figure 6) and believed that it would be relevant and of interest to other patients diagnosed with colorectal cancer.

 

Table of Contents

Top of Page